The effect of Montelukast on symptoms of children with bladder pain syndrome

Phase 2

• Conditions: Bladder pain syndrome.; Other symptoms and signs involving the genitourinary system; R39.89

• Registration Number: IRCT20210628051728N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 12 July 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

All 3-18 year old children with bladder pain syndrome who were referred to Amirkabir hospital pediatric clinic of Arak city
All 3-18 year old children with bladder pain syndrome who were admitted to Amirkabir hospital ward of Arak city
Allergy history

Exclusion Criteria

Allergy history to Montelukast

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Decrease nocturia. Timepoint: days0-14. Method of measurement: questionnaire(numbers).;Alleviate bladder pain. Timepoint: days0-14. Method of measurement: questionnaire(mild/moderate/severe).;Decrease urinary Incontinency. Timepoint: days 0-14. Method of measurement: questionnaire(numbers).;Decrease urinary urgency. Timepoint: days 0-14. Method of measurement: questionnaire(numbers).;Decrease urinary frequency. Timepoint: days 0-14. Method of measurement: questionnaire(numbers).